Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • BI 1181181 - Healthy
    Clinical Study Number 1344.2
    Study Indication Healthy
    Product BI 1181181
    Generic Name BI 1181181
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of BI 1181181 given orally q.d. for 10 days in young healthy male and elderly healthy male/female volunteers (randomized, double-blind, placebo controlled within dose groups, Phase I study)

    Study Document
    Trial statement 1344.2 english